We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BR:NYSEBroadridge Financial Solutions, Inc. Analysis

Data as of 2026-08-15 - not real-time

$171.01

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Broadridge Financial Solutions, Inc. trades at $171.01, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 18.8%. Momentum indicators put RSI at 64.7 (approaching overbought) with MACD reading bullish. Watch $143.04 as support and $176.94 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 17.8 versus a 36.5 sector average, below the peer group. Consensus targets land 24.7% above where the shares trade now. Revenue is growing at 7.5% on a 15.0% profit margin. The 2.55% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 38.3%, a beta of 0.12 and a maximum drawdown of 48.5%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.

Top Market Events

Financial technology provider Broadridge NYSE:BR reported Q2 CY2026 results beating Wall Street’s revenue...Financial technology provider Broadridge NYSE:BR will be announcing earnings results this Tuesday morning.Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2026 Results on August 4,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 180.39
  • MACD momentum is positive
  • 30-day price change of +18.8%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 17.8 versus sector average of 36.5
  • Trading below the 200-day average of 180.39
  • Analyst targets imply +24.7% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 17.8 versus sector average of 36.5
  • Analyst targets imply +24.7% versus the current price
  • Profit margin of 15.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin15.04%
P/E Ratio17.8
ROE40.92%
ROA9.29%
Debt/Equity123.94
P/B Ratio7.0
Op. Cash Flow$1.3B
Free Cash Flow$1.2B
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI64.7
Support$143.04
Resistance$176.94
MA 20$159.42
MA 50$150.39
MA 200$180.39
MACDBullish
VolumeIncreasing
Fear & Greed Index95.98

Valuation

Fair Value$156.36
Target Price$213.25
Upside/Downside24.70%
GradeUndervalued
TypeBlend
Dividend Yield2.55%

Risk Assessment

Beta0.12
Volatility38.29%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.